+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sulfasalazine"

From
Psoriatic Arthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 180 Pages
  • Global
From
US Axial Spondyloarthritis Market outlook to 2028 - Product Thumbnail Image

US Axial Spondyloarthritis Market outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
From
From
Africa Anti-Rheumatic Drugs Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Africa Anti-Rheumatic Drugs Market - Forecasts from 2023 to 2028

  • Report
  • February 2023
  • 135 Pages
  • Africa
From
Indonesia Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Indonesia Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • October 2022
  • 74 Pages
  • Indonesia
From
Axial spondyloarthritis (axSpA) Market and Forecast Analysis to 2037 - Product Thumbnail Image

Axial spondyloarthritis (axSpA) Market and Forecast Analysis to 2037

  • Drug Pipelines
  • July 2018
  • 393 Pages
  • Global
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Sulfasalazine is a drug used to treat immune disorders, such as rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It works by reducing inflammation and suppressing the immune system. It is usually taken orally, but can also be administered intravenously. Side effects of sulfasalazine include nausea, vomiting, and abdominal pain. Sulfasalazine is a generic drug, meaning it is available in many different forms and from many different manufacturers. It is also available in combination with other drugs, such as methotrexate and hydroxychloroquine. The cost of sulfasalazine varies depending on the manufacturer and form. The sulfasalazine market is highly competitive, with many different manufacturers offering their own versions of the drug. Companies in the market include Pfizer, Merck, Novartis, and Teva Pharmaceuticals. Show Less Read more